Fund Holdings — Euclidean Capital LLC

Total Portfolio Value
$305.72M
Total Bought
$23.86M
Total Sold
$802.6K
Net Transaction
+$23.06M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
VANGUARD INTL EQUITY INDEX F1,991,8842,142,684+150,800120,828144,03147.11%+23,204
ISHARES TR
MSCI INDIA ETF
2,425,1442,425,1440124,846135,03244.17%+10,186
ORIC PHARMACEUTICALS INC(ORIC)989,410989,41005,52110,0433.28%+4,522
FOGHORN THERAPEUTICS INC(FHTX)1,573,7611,573,76105,7447,3972.42%+1,652
RAPT THERAPEUTICS INC082,234+82,23406580.22%+658
SPDR S&P 500 ETF TR(SPY)4,1044,10402,2962,5360.83%+240
ALECTOR INC1,307,8581,307,85801,6091,8310.60%+222
TENAYA THERAPEUTICS INC(TNYA)1,015,7051,015,70505796210.20%+42
SURROZEN INC(SRZN)170,833170,8330530.00%-2
PMV PHARMACEUTICALS INC(PMVP)2,627,6432,627,64302,8642,7850.91%-79
SURROZEN INC(SRZN)87,69687,69601,0237840.26%-239
RAPT THERAPEUTICS INC657,8990-657,8998030—-803
Page 1 of 1